CVAC has every chance to be fast tracked to FDA approvals in about 2 - 2.5 years from now if signs remain positive.
I think it will be a very sought after drug, but just considering the UNMET NEED for OV sufferers, it's bound to be accelerated in various jurisdictions.
- Forums
- ASX - By Stock
- benefits of priority review and orphan status
CVAC has every chance to be fast tracked to FDA approvals in...
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $417.6M |
Open | High | Low | Value | Volume |
28.5¢ | 30.5¢ | 28.5¢ | $280.6K | 944.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 148043 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 115119 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 148043 | 0.300 |
14 | 230651 | 0.295 |
16 | 415373 | 0.290 |
26 | 401367 | 0.285 |
38 | 1504223 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 115118 | 16 |
0.310 | 146436 | 12 |
0.315 | 94654 | 6 |
0.320 | 49206 | 4 |
0.325 | 31900 | 2 |
Last trade - 12.39pm 19/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |